TMCnet News

NovaBone Products Secures Approval of CE Mark for Collagen Devices
[September 26, 2016]

NovaBone Products Secures Approval of CE Mark for Collagen Devices


NovaBone Products, a private biologics medical device company, today announced that it has received CE mark approval for NovaTape™ and NovaPlug™, dental wound dressing products.

NovaTape™ and NovaPlug™ are 100% collagen based products designed for management of soft tissue oral wounds and sores, including dental sores, oral ulcers (non-infected or viral), periodontal surgical wounds, suture sites, burns, extraction sites, surgical and traumatic wounds. Since 2015, NovaBone Products has lead industry development of collagen-based products for the medical community.

"The CE mark approval is a major milestone for our company and a benefit to physicians and dentist in the European Union," said Art Wotiz, President of NovaBone Products. "NovaTape™ and NovaPlug™ are exceptionally user-friendly and proven to be effective for a range of indications. It is important to note that NovaBone now has comprehensive capabilities to produce intuitively-designed bioactive collagen composites and collagen-only products that meet the demands of medical professionals."



About NovaBone

NovaBone is a privately held company based in Florida, USA since 2002. NovaBone developed the first bioactive synthetic bone graft offered to the orthopedic community and has long been at the forefront of bioactive glass bone graft devices. More recently, NovaBone established core competency in developing collagen devices. NovaBone provides seven devices within the field of orthopedics and six for dental indications providing the medical community with unparalleled versatility and the widest range of choices in bioactive graft devices.



[ Back To TMCnet.com's Homepage ]